Transforming Growth Factor β Depletion Is the Primary Determinant of Smad Signaling Kinetics

被引:51
|
作者
Clarke, David C. [1 ,2 ]
Brown, Meredith L. [1 ]
Erickson, Richard A. [1 ]
Shi, Yigong [3 ]
Liu, Xuedong [1 ]
机构
[1] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA
[2] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA
[3] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
基金
美国国家卫生研究院;
关键词
BMP ACTIVITY GRADIENT; TGF-BETA; MORPHOGEN GRADIENT; MEDIATED ENDOCYTOSIS; TUMOR-SUPPRESSOR; XENOPUS CELLS; RECEPTOR; PROTEIN; TRANSDUCTION; ACTIVIN;
D O I
10.1128/MCB.01443-08
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cell's decision to growth arrest, apoptose, or differentiate in response to transforming growth factor beta (TGF-beta) superfamily ligands depends on the ligand concentration. How cells sense the concentration of extracellular bioavailable TGF-beta remains poorly understood. We therefore undertook a systematic quantitative analysis of how TGF-beta ligand concentration is transduced into downstream phospho-Smad2 kinetics, and we found that the rate of TGF-beta ligand depletion is the principal determinant of Smad signal duration. TGF-beta depletion is caused by two mechanisms: (i) cellular uptake of TGF-beta by a TGF-beta type II receptor-dependent mechanism and (ii) reversible binding of TGF-beta to the cell surface. Our results indicate that cells sense TGF-beta dose by depleting TGF-beta via constitutive TGF-beta type II receptor trafficking processes. Our results also have implications for the role of the TGF-beta type II receptor in disease, as tumor cells harboring TGF-beta type II receptor mutations exhibit impaired TGF-beta depletion, which may contribute to the overproduction of TGF-beta and a consequently poor prognosis in cancer.
引用
收藏
页码:2443 / 2455
页数:13
相关论文
共 50 条
  • [21] Axin facilitates Smad3 activation in the transforming growth factor β signaling pathway
    Furuhashi, M
    Yagi, K
    Yamamoto, H
    Furukawa, Y
    Shimada, S
    Nakamura, Y
    Kikuchi, A
    Miyazono, K
    Kato, M
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) : 5132 - 5141
  • [22] Functional characterization of transforming growth factor β signaling in Smad2-and Smad3-deficient fibroblasts
    Piek, E
    Ju, WJ
    Heyer, J
    Escalante-Alcalde, D
    Stewart, CL
    Weinstein, M
    Deng, CX
    Kucherlapati, R
    Böttinger, EP
    Roberts, AB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) : 19945 - 19953
  • [23] BCL6 represses smad signaling in transforming growth factor-β resistance
    Wang, Degang
    Long, Jianyin
    Dai, Fangyan
    Liang, Min
    Feng, Xin-Hua
    Lin, Xia
    CANCER RESEARCH, 2008, 68 (03) : 783 - 789
  • [24] Zili Inhibits Transforming Growth Factor-β Signaling by Interacting with Smad4
    Sun, Huaqin
    Li, Dan
    Chen, Shu
    Liu, Yanyan
    Liao, Xiaolin
    Deng, Wenqian
    Li, Na
    Zeng, Mei
    Tao, Dachang
    Ma, Yongxin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (06) : 4243 - 4250
  • [25] Smad7 differentially regulates transforming growth factor β-mediated signaling pathways
    Zhu, HJ
    Iaria, J
    Sizeland, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32258 - 32264
  • [26] BF-1 interferes with transforming growth factor β signaling by associating with Smad partners
    Dou, CL
    Lee, J
    Liu, B
    Liu, F
    Massague, J
    Xuan, SH
    Lai, E
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (17) : 6201 - 6211
  • [27] Novel mutations in smad proteins that inhibit signaling by the transforming growth factor β in mammalian cells
    Prokova, Vassiliki
    Mavridou, Sofia
    Papakosta, Paraskevi
    Petratos, Kyriacos
    Kardassis, Dimitris
    BIOCHEMISTRY, 2007, 46 (48) : 13775 - 13786
  • [29] THE ROLE OF CONNECTIVE TISSUE GROWTH FACTOR, TRANSFORMING GROWTH FACTOR Β1 AND SMAD SIGNALING PATHWAY IN CORNEA WOUND HEALING
    WU Xinyi YANG Yongmei GUO Hui and CHANG YuanDepartment of Ophthalmology Qilu Hospital Shandong University Jinan China
    ChineseMedicalJournal, 2006, (01) : 57 - 62
  • [30] Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling
    Baldwin, RL
    Tran, H
    Karlan, BY
    CANCER RESEARCH, 2003, 63 (06) : 1413 - 1419